(Q42228871)

English

Tenofovir/emtricitabine/efavirenz plus rosuvastatin decrease serum levels of inflammatory markers more than antiretroviral drugs alone in antiretroviral therapy-naive HIV-infected patients

scientific article published on January 2014

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Tenofovir/emtricitabine/efavirenz plus rosuvastatin decrease serum levels of inflammatory markers more than antiretroviral drugs alone in antiretroviral therapy-naive HIV-infected patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

anti-retroviral agent

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Pierluigi Viale

9

object named as

Pierluigi Viale

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

author name string

Leonardo Calza

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Elisa Vanino

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Caterina Salvadori

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Roberto Manfredi

4

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Vincenzo Colangeli

5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Alessandra Cascavilla

6

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Maria Assunta Di Bari

7

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Roberto Motta

8

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

publication date

1 January 2014

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

HIV Clinical Trials

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1-13

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

Statins and lipid metabolism: an update

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

C-reactive protein lowering with rosuvastatin in the METEOR study

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

Pleiotropic effects of statins. - Basic research and clinical perspectives -.

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

Induction of endothelial nitric oxide synthase, SIRT1, and catalase by statins inhibits endothelial senescence through the Akt pathway.

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

Preoperative atorvastatin treatment in CABG patients rapidly improves vein graft redox state by inhibition of Rac1 and NADPH-oxidase activity

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

Statins suppress interleukin-6-induced monocyte chemo-attractant protein-1 by inhibiting Janus kinase/signal transducers and activators of transcription pathways in human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

Statins protect against fulminant pneumococcal infection and cytolysin toxicity in a mouse model of sickle cell disease

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

Inflammatory and coagulation biomarkers and mortality in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

Inflammation, coagulation and cardiovascular disease in HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

Association of C-reactive protein and HIV infection with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

Persistently elevated serum interleukin-6 predicts mortality among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

C-reactive protein is a marker for human immunodeficiency virus disease progression.

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

Mechanisms for the anti-inflammatory effects of statins

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

Statins and inflammation: an update

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

Effect of rosuvastatin on ROCK activity, endothelial function, and inflammation in Asian patients with atherosclerosis.

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

Lovastatin inhibits HIV-1 expression in H9 human T lymphocytes cultured in cholesterol-poor medium

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

Statin compounds reduce human immunodeficiency virus type 1 replication by preventing the interaction between virion-associated host intercellular adhesion molecule 1 and its natural cell surface ligand LFA-1.

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

Evaluation of the anti-HIV activity of statins

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

Statin-induced inhibition of HIV-1 release from latently infected U1 cells reveals a critical role for protein prenylation in HIV-1 replication

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

The effect of atorvastatin treatment on HIV-1-infected patients interrupting antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

Pravastatin does not have a consistent antiviral effect in chronically HIV-infected individuals on antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trial

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-α in HIV-infected patients treated with ritonavir-boosted protease inhibitors

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

Association between use of HMG CoA reductase inhibitors and mortality in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

Statin therapy and mortality in HIV-infected individuals; a Danish nationwide population-based cohort study

1 reference

https://api.crossref.org/works/10.1310%2FHCT1501-1

21 January 2018

Identifiers

10.1310/HCT1501-1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42228871&oldid=1937116435"